Management PharmAccess
Monique Dolfing-Vogelenzang
Chief Executive Officer
Jan Willem Marees
Chief Financial Officer
In October 2008 Jan Willem Marees joined PharmAccess International as CFO. During his period at PharmAccess several spin-offs have been established: Health Insurance Fund, Medical Credit Fund, SafeCare Foundation and HealthConnect. After bringing together these spin-offs in one group Jan Willem is CFO of PharmAccess Group Foundation.
Prior to joining PharmAccess, Jan Willem held similar positions in the private sector: Finance Director at Solvay Pharma, at an IT start up (MarviQ) and in the Dutch healthcare sector at Medial.
Arjan Poels
Managing Director Medical Credit Fund
Arjan is the Managing Director of the Medical Credit Fund (MCF), a not-for profit organization based in Amsterdam, the Netherlands. He oversees MCF’s performance, operations and country offices. MCF was launched in 2009 to improve the availability of loans to health SMEs.
Arjan joined MCF in 2017 after a banking career of 18 years, 10 of which in Africa in senior executive roles. He has expertise in SME lending, commercial and risk management, development finance and change management.
He holds a Master of Science degree in Aerospace Engineering of Delft Technical University, the Netherlands and has a passion for development finance and SMEs
Kwasi Boahene
Advocacy Director
Nicole Spieker
Quality Director
Nicole Spieker is Director Quality, responsible for managing SafeCare within PharmAccess Group. SafeCare is operational in over 2500 facilities in Sub-Saharan Africa with public and private sector partners amongst which Lagos State of Nigeria and the MoH&SW in Tanzania. She is leading SafeCare transitioning into a sustainable business model and scaling to other emerging markets.
Second, she is Director East Africa, responsible for overseeing the innovation agenda of PharmAccess in East Africa. At the core is the M-TIBA health exchange platform in partnership with CarePay.Prior to this, Nicole Spieker was Director of clinical support services at the Aga Khan Health Services, Tanzania and assistant professor at Aga Khan University. She holds a PhD in Molecular Genetics of the University of Amsterdam, The Netherlands.
Njide Ndili
Country Director - Nigeria
Njide Ndili is the Country Director for PharmAccess Foundation Nigeria Office. In this role she has oversight of all in country activities including supporting demand side financing, supply side quality improvement and activities to improve access to finance. She has over 20 years experience in the healthcare industry in the United States and Nigeria.
Njide was the CEO Lionstone Healthcare Partners, a consulting company focused on Healthcare Information technology. Prior to this, she was the CEO of Hygeia Community Health Care and the COO of Hygeia HMO. Before she relocated to Nigeria in 2003, Njide was the Regional Director for operations at CIGNA Healthcare Houston. Njide also holds a position on the Board of SQHN.
Njide has a MSc in Health Economics, Policy and Management from London School of Economics, an AMP from INSEAD Business School, Fontainebleau France, an MBA from the University of Houston, a Post Graduate Diploma in Finance and a BSc. in Computer Science from the University of Nigeria.
Isaiah Okoth
Country Director - Kenya
Maxwell Antwi
Country Director - Ghana
Heri Marwa
Country Director - Tanzania
Tobias Rinke de Wit
Research Director
Mark van der Graaf
Director Data & Health Technology
Madelon Cabooter
Program and Resource Mobilization Director
Executive Board
The Executive Board of the Stichting PharmAccess Group Foundation operates as the Executive Statutory Board for all the underlying foundations within the organization, including Stichting PharmAccess International.
Members of the Executive Board of Stichting PharmAccess Group Foundation are:
Monique-Dolfing Vogelenzang, Chief Executive Officer
Jan Willem Marees, Chief Financial Officer
Supervisory Board
The Supervisory Board of Stichting PharmAccess Group Foundation supervises the Executive Board of Stichting PharmAccess Group Foundation in its role of Statutory Board for all underlying foundations, including Stichting PharmAccess International.
The members of the Supervisory Board are:
Pauline Meurs – Vice Chairperson
Pauline is currently a Professor of Healthcare Governance at the Erasmus University Rotterdam and Chair of the Board of the National Council for Health and Society (RvS). She is the founder and Scientific Director of the Erasmus Centre for Health Care Management, which offers tailor-made postgraduate and executive programs for managers and CEOs of healthcare organizations. Among others, she is a member of the board of the University of Amsterdam and the Amsterdam Medical Centre.
Ben Christiaanse – Board Member
Ben Christiaanse has over 40 years of banking experience. In 2006 he was appointed as CEO of National Microfinance Bank in Tanzania. He developed NMB into one of the largest financial institutes of Tanzania, and successfully managed an IPO of part of the share capital of the bank in 2006. In 2010 he established his own consultancy that focused on financial institutes in developing countries. Ben now serves as a board member in several African Banks and is member of the supervisory board of two Dutch organizations.
Willem van Duin – Board Member
Willem van Duin started his career with Achmea in 1987. Before he was appointed in the Executive Board in 2004, he held various positions at Holding level as well as board positions. He holds board positions in the Dutch Association of Insurers (Verbond van Verzekeraars, vice-chairman), VNO-NCW (the Dutch employers’ organization) and National Cooperative Council. Willem is currently one of the vice-chairmen of the council of iFHP (International Federation of Health Plans) and chairman of the board of the European Alliance Partners ‘Eurapco’ (an association of European mutual insurance companies).
Christiaan Rebergen – Board Member
Christiaan Rebergen is the Treasurer-General at the Dutch Ministry of Finance. He is responsible for financial markets, the Dutch treasury agency, foreign financial relations and Dutch state enterprises. Before he joined the Ministry of Finance, he was Director-General for International Cooperation at the Ministry of Foreign Affairs overseeing the Dutch aid portfolio of €4 billion. Previous positions held by Mr. Rebergen are Special Ambassador for the Millennium Development Goals, Ambassador for Public Private Partnerships, Deputy Director of the Sustainable Economic Development Department and head of the Budget.
Ruud Hopstaken – Board Member
Ruud Hopstaken has held executive positions at organizations like Buma/Stemra, PriceWaterhouseCoopers and the Amsterdam Medical Centre. Ruud is chairman of the Supervisory Board of GGNet (Institution for mental health care) and the Institute for Positive Health (IPH). He is also board member of various boards and committees within the health (insurance) sector.
Peter van Rooijen – Board Member
Peter Van Rooijen is the Executive Director of International Civil Society Support. He also serves on the Boards of i+solutions, the Amsterdam Health & Technology Institute and the Joep Lange Institute. He has been involved in HIV/AIDS since 1984, initially as volunteer, later as a psychotherapist and director of Care Services at the Schorer Foundation (Amsterdam). In 1992 he was the director of the Dutch National Committee on AIDS Control. From 1993-2005 he served as the executive director of Aids Fonds (established in 1986) and STOP AIDS NOW!
Lidwin van Velden – Board Member
Lidwin van Velden is a member of the management board of the Nederlandsche Waterschapsbank (NWB Bank), having taken on the role of CFO/CRO in 2010. She also serves on the Supervisory Board of Centraal Beheer Algemeen Pensioenfonds, and is a member of the Audit Committee of the Dutch Ministry of Education, Culture and Science. She has built extensive experience in financial markets, asset management and risk management. Before joining NWB Bank, Lidwin held various managerial positions at De Nederlandse Bank (DNB) within the Financial Markets and Supervision divisions.